Dr. Reddy’s Laboratories has launched ‘Obeda’, an injectable semaglutide therapy for diabetes and weight management in India.

This episode, titled Optimizing Subcutaneous Therapies in NSCLC: Practical Integration, Patient Selection, and Workflow ...

GLP-1 medications like Ozempic, Wegovy and Mounjaro have become something of a cultural lightning rod over the past few years ...

Dr Reddy’s Labs launches India’s first DCGI-approved semaglutide injection ‘Obeda’ for type 2 diabetes: Our Bureau, Mumbai Saturday, March 21, 2026, 13:30 Hrs [IST] Dr Red ...

This episode of The Vet Blast Podcast reveal how in-home can be a benefit to professionals, clients, and patients. On this ...

Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...

While the introduction of branded generics is likely to accelerate volumes for GLP-1 agonists, value growth may moderate because of price erosion.

India, March 21 -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associate companies) today ...

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.

An experimental mRNA cancer vaccine developed with the help of artificial intelligence (AI) has shown promising results after successfully shrinking a ...

Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being ...

Rhythm Pharmaceuticals’ setmelanotide receives US FDA approval to treat patients living with acquired hypothalamic obesity: Boston Saturday, March 21, 2026, 18:00 Hrs [IST] Rhyt ...